ZFIN Image: Zhou et al., 2021, Fig. 2

Image

Figure Caption

Fig. 2

Perillaldehyde promoted angiogenesis of zebrafish. (A) Fluorescent images of blood vessels of zebrafish: a. control; b. treatment with 1.5 µg/mL sunitinib; c. treatment with 1.5 µg/mL sunitinib plus 3.13 µM perillaldehyde; d. treatment with 1.5 µg/mL sunitinib plus 6.25 µM perillaldehyde; e. treatment with 1.5 µg/mL sunitinib plus 12.5 µM perillaldehyde; f. treatment with 1.5 µg/mL sunitinib plus 25 µM perillaldehyde; g. treatment with 1.5 µg/mL sunitinib plus 50 µM perillaldehyde. The images of h–n were partial enlargements of images a–g. (B) Perillaldehyde promoted angiogenesis of sunitinib-injured zebrafish. ^##P < 0.01 vs untreated control, **P < 0.01 vs sunitinib, *P < 0.05 vs sunitinib.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Drug Des Devel Ther